Results 91 to 100 of about 22,744 (213)

DNA‐Based Liquid Biopsy for Evaluating Surgical and Postsurgical Outcomes in Gynecologic Malignancies: A Systematic Review

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 1, January 2026.
Liquid biopsy using plasma and uterine aspirate samples provides a minimally invasive tool for detecting and monitoring gynecologic cancers. Circulating tumor DNA (ctDNA) and cell‐free DNA (cfDNA) enable prognosis, treatment response assessment, and improved diagnostic accuracy across various tumor types. ABSTRACT Introduction DNA‐based liquid biopsies,
Samaneh Yavari   +13 more
wiley   +1 more source

Extreme Levels of Platelet Count in Essential Thrombocythemia: Management and Outcome, Report of Two Cases

open access: yesCase Reports in Oncology, 2020
Myeloproliferative neoplasms including essential thrombocythemia (ET) is usually caused by somatic mutations in multiple genes, including the JAK2 (most frequently), CALR gene, and MPL. In rare cases, the disease is caused by other mutations such as THPO
Mohammad Abu-Tineh, Mohamed A. Yassin
doaj   +1 more source

Pelvic floor disorders in gynecological malignancies. An overlooked problem? [PDF]

open access: yes, 2018
Cervical, endometrial, ovarian, vulvar, and vaginal cancers affect women of a broad age spectrum. Many of these women are still sexually active when their cancer is diagnosed.
Bodean, Oana M.   +7 more
core   +3 more sources

In Vitro Chemosensitivity Using the Histoculture Drug Response Assay in Human Epithelial Ovarian Cancer [PDF]

open access: yes, 2012
The choice of chemotherapeutic drugs to treat patients with epithelial ovarian cancer has not depended on individual patient characteristics. We have investigated the correlation between in vitro chemosensitivity, as determined by the histoculture drug ...
Kim, Dae-Yeon   +6 more
core   +1 more source

Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer [PDF]

open access: gold, 2023
Camilla Certelli   +9 more
openalex   +1 more source

Neoadjuvant Glucocorticoids Facilitate Resection in Advanced B‐Type Thymomas: A Propensity‐Matched Analysis of Surgical and Survival Outcomes

open access: yesThoracic Cancer, Volume 17, Issue 1, January 2026.
Neoadjuvant glucocorticoids facilitated less invasive and more complete resection of advanced B‐type thymomas, leading to reduced operative morbidity and improved progression‐free survival compared to upfront surgery. This study supports a novel downstaging strategy for this challenging disease.
Zhen Yu   +7 more
wiley   +1 more source

Mediastinal Metastasis Isolated in Ovarian Cancer: A Systematic Review

open access: yesLife
Background: Isolated mediastinal metastases from ovarian carcinoma are considered exceptional. Since such metastases are considered advanced stage disease, systemic therapy is the indicated therapeutic approach; however, some articles report that ...
Victoria Psomiadou   +2 more
doaj   +1 more source

Comparison of Long-Term Survival Rates of Primary Surgery and Surgery After Neoadjuvant Chemotherapy in Ovarian Cancer

open access: yesİstanbul Medical Journal, 2019
Introduction:To compare long-term survival of primary debulking surgery (PDS) and interval debulking surgery (IDS) after neoadjuvant chemotherapy (NAC) in patients with advanced ovarian cancer.Methods:Patients who underwent debulking surgery for ovarian ...
Alpaslan Kaban   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy